Notice2025-20483
National Cancer Institute; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 21, 2025
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 223 (Friday, November 21, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 223 (Friday, November 21, 2025)]
[Notices]
[Pages 52683-52684]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-20483]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Cancer
Advisory Board.
The meeting will be held virtually and is open to the public, as
indicated below. Individuals who plan to view the virtual meeting and
require special assistance or other reasonable accommodation should
notify the Contact Person listed below in advance of the meeting. The
meeting can be accessed from the NIH Videocast at the following link:
<a href="http://videocast.nih.gov/">http://videocast.nih.gov/</a>. A portion of the meeting will be closed to
the public in accordance with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended. The intramural programs and
projects and the discussions could disclose confidential trade secrets
or commercial property such as patentable material, and personal
information concerning
[[Page 52684]]
individuals associated with the intramural programs and projects, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer Advisory Board.
Date: December 2, 2025.
Open: 10:00 a.m. to 1:20 p.m.
Agenda: NCAB Subcommittee Meetings.
Open: 1:30 a.m. to 4:00 p.m.
Agenda: Opening Remarks and Business of the Board.
Closed: 4:15 p.m. to 5:00 p.m.
Agenda: To review and evaluate the intramural program, site
visit outcomes and discussions of confidential personnel issues.
Address: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Rockville, MD 20850.
Meeting Format: Virtual Meeting.
Contact Person: Shamala K. Srinivas, Ph.D., Associate Director,
Division of Extramural Activities, National Cancer Institute--Shady
Grove, National Institutes of Health, 9609 Medical Center Drive, 7th
Floor, Room. 7W530, Bethesda, MD 20892, 240-276-6340,
<a href="/cdn-cgi/l/email-protection#c9baa1a8a4a8a5a889a4a8a0a5e7a7a0a1e7aea6bf"><span class="__cf_email__" data-cfemail="ddaeb5bcb0bcb1bc9db0bcb4b1f3b3b4b5f3bab2ab">[email protected]</span></a>.
Late Notice Text: This notice is being published less than 15
days from the meeting date due to exceptional circumstances. The
National Cancer Advisory Board (NCAB) meeting date could not be
confirmed until the appointment of the new NCI Director, Dr. Anthony
Letai, which occurred on September 30, 2025. As of the next day,
October 1, 2025, it was not possible to publish the meeting notice
for the NCAB as a result of the 43-day government shutdown, due to
lapsed appropriations.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: NCAB: <a href="http://cancer.gov">http://cancer.gov</a>, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Zieta M. Charles,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-20483 Filed 11-20-25; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 21, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.